Literature DB >> 20583666

DNA drugs come of age.

Matthew P Morrow1, David B Weiner.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20583666     DOI： 10.1038/scientificamerican0710-48

Source DB:  PubMed          Journal:  Sci Am        ISSN： 0036-8733            Impact factor:   2.142


× No keyword cloud information.
  12 in total

1.  Non-contact helium-based plasma for delivery of DNA vaccines. Enhancement of humoral and cellular immune responses.

Authors:  Richard J Connolly; Taryn Chapman; Andrew M Hoff; Michele A Kutzler; Mark J Jaroszeski; Kenneth E Ugen
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

2.  DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge.

Authors:  Veronica L Scott; Daniel O Villarreal; Natalie A Hutnick; Jewell N Walters; Edwin Ragwan; Khalil Bdeir; Jian Yan; Niranjan Y Sardesai; Adam C Finnefrock; Danilo R Casimiro; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  Synthetic DNA vaccine strategies against persistent viral infections.

Authors:  Daniel O Villarreal; Kendra T Talbott; Daniel K Choo; Devon J Shedlock; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2013-05       Impact factor: 5.217

Review 4.  Of microneedles and ultrasound: Physical modes of gastrointestinal macromolecule delivery.

Authors:  Carl M Schoellhammer; Robert Langer; Giovanni Traverso
Journal:  Tissue Barriers       Date:  2016-02-11

5.  Enhancement of antigen specific humoral immune responses after delivery of a DNA plasmid based vaccine through a contact-independent helium plasma.

Authors:  Richard J Connolly; Jose I Rey; Vance M Lambert; Garrett Wegerif; Mark J Jaroszeski; Kenneth E Ugen
Journal:  Vaccine       Date:  2010-12-31       Impact factor: 3.641

6.  Evolution of drug delivery systems: From 1950 to 2020 and beyond.

Authors:  Haesun Park; Andrew Otte; Kinam Park
Journal:  J Control Release       Date:  2021-12-29       Impact factor: 11.467

7.  Electrogenetherapy of B16.F10 murine melanoma tumors with an interleukin-28 expressing DNA plasmid.

Authors:  Kevin Shah; Richard J Connolly; Taryn Chapman; Mark J Jaroszeski; Kenneth E Ugen
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

8.  Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine.

Authors:  Huihui Bao; Aarti A Ramanathan; Omkar Kawalakar; Senthil G Sundaram; Colleen Tingey; Charoran B Bian; Nagarajan Muruganandam; Paluru Vijayachari; Niranjan Y Sardesai; David B Weiner; Kenneth E Ugen; Karuppiah Muthumani
Journal:  Viral Immunol       Date:  2013-02       Impact factor: 2.257

9.  Ultrasound-mediated gastrointestinal drug delivery.

Authors:  Carl M Schoellhammer; Avi Schroeder; Ruby Maa; Gregory Yves Lauwers; Albert Swiston; Michael Zervas; Ross Barman; Angela M DiCiccio; William R Brugge; Daniel G Anderson; Daniel Blankschtein; Robert Langer; Giovanni Traverso
Journal:  Sci Transl Med       Date:  2015-10-21       Impact factor: 17.956

10.  Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice.

Authors:  Veronica L Scott; Ami Patel; Daniel O Villarreal; Scott E Hensley; Edwin Ragwan; Jian Yan; Niranjan Y Sardesai; Paul J Rothwell; Jonathan P Extance; Lisa J Caproni; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.